Cost-Effectiveness of Hepatitis C Treatment for People Who Inject Drugs and the Impact of the Type of Epidemic; Extrapolating from Amsterdam, the Netherlands

Por van Santen, Daniëla K., de Vos, Anneke S., Matser, Amy, Willemse, Sophie B., Lindenburg, Karen, Kretzschmar, Mirjam E. E., Prins, Maria, de Wit, G. Ardine
Publicado no PLoS One (2016)

Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co‐infected HIV patients with cirrhosis

Por Willemse, Sophie, Smit, Colette, Sogni, Philippe, Sarcletti, Mario, Uberti‐Foppa, Caterina, Wittkop, Linda, Raben, Dorthe, D'Arminio Monforte, Antonella, Dabis, Francois, Van Der Valk, Marc
Publicado no J Viral Hepat (2019)

Dynamics of the Immune Response in Acute Hepatitis B Infection

Por Stelma, Femke, Willemse, Sophie B, Erken, Robin, de Niet, Annikki, Sinnige, Marjan J, van Dort, Karel, Zaaijer, Hans L, van Leeuwen, Ester M M, Kootstra, Neeltje A, Reesink, Hendrik W
Publicado no Open Forum Infect Dis (2017)

A single dose of anti-miR-122, RG-101, in CHC patients results in NK cell normalization with no effect on HCV-specific CD8+ T cell function

Por Stelma, Femke, van der Ree, Meike H, Sinnige, Marjan J, Brown, Anthony, Swadling, Leo, de Vree, J Marleen L, Willemse, Sophie B, van der Valk, Marc, Grint, Paul, Neben, Steven, Klenerman, Paul, Barnes, Eleanor, Kootstra, Neeltje A, Reesink, Hendrik W
Publicado no Hepatology (2017)

Limited Generalizability of Registration Trials in Hepatitis C: A Nationwide Cohort Study

Por Berden, Floor A. C., de Knegt, Robert J., Blokzijl, Hans, Kuiken, Sjoerd D., van Erpecum, Karel J. L., Willemse, Sophie B., den Hollander, Jan, van Vonderen, Marit G. A., Friederich, Pieter, van Hoek, Bart, van Nieuwkerk, Carin M. J., Drenth, Joost P. H., Kievit, Wietske
Publicado no PLoS One (2016)